Patients with acne vulgaris who received systemic therapies had greater rates of treatment adherence and satisfaction than with topical therapies.
Treatment with abrocitinib, an oral JAK1 inhibitor, led to substantial improvements in the signs and symptoms of chronic hand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results